Gastrointestinal Stromal Tumour (GIST) Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Endoscopic resection for the treatment of gastric gastrointestinal stromal tumors: a retrospective study from a large tertiary hospital in China
ConclusionER is an appropriate alternative method for the treatment of gastric GISTs, with an en bloc resection rate of 88.85% and a complication rate of 0.93%. No recurrence was noted during follow-up, even for GISTs with piecemeal resection. (Source: Surgical Endoscopy)
Source: Surgical Endoscopy - December 26, 2023 Category: Surgery Source Type: research

FBXW7 regulates the sensitivity of imatinib in gastrointestinal stromal tumors by targeting MCL1
ConclusionsFBXW7 regulates imatinib sensitivity by inhibiting MCL1 to enhance imatinib-induced apoptosis in GIST, and predicts efficacy of imatinib treatment in high-risk GIST patients treated with imatinib. (Source: Gastric Cancer)
Source: Gastric Cancer - December 24, 2023 Category: Gastroenterology Source Type: research